Table 4.

Mean use of resources during a 3-month acupuncture treatment and a 6-month follow-up

	Acupuncture group N=42			Control group N=44			P-value
Baseline year	N	Mean	SD	N	Mean	SD
Rescue/prophylactic medication (ATC/DDD)a	42	14.8/9.6	(14.3/11.9)	44	11.5/7.2	(11.8/11.9)	NS
Outpatient visits, n	42	1.0	0.7	44	1.0	0.8	NS
Productivity loss, working days	42	0.1	0.1	44	0.1	0.2	NS
Loss of income, unpaid working days	42	0.0	0.1	44	0.0	0.1	NS
Emergency visits	42	0.4	0.5	42	0.3	0.6	NS
Hospitalization	40	0.0	0.0	41	0.0	0.0	NS
Adverse drug reactions, n (%)	41	9	(22.0)	41	10	(24.4)	NS
Acupuncture treatment (3 months)
Rescue medication (ATC/DDD)a	42	26.1	41.4	42	26.8	27.5	NS
Acupuncture visits, n	42	13.5	0.7
Productivity loss, working days	42	0.8	1.4
Loss of income, unpaid working days	42	0.3	0.9
Outpatient visits, n	42	1.0	1.0	42	1.0	0.9	NS
Productivity loss, working days	42	0.1	0.2	42	0.1	0.1	NS
Loss of income, unpaid working days	42	0.0	0.1	42	0.0	0.1	NS
Emergency visits	42	0.1*	0.4	42	0.2	0.5	NS
Hospitalization	42	0.0	0.0	42	0.0	0.0	NS
Adverse drug reactions, n (%)	42	2	(4.8)	40	6	(15.0)	NS
6-month follow-up
Rescue medication (ATC/DDD)a	40	26.6	50.8	41	28.4	31.9	NS
Outpatient visits, n	40	0.7	0.7	41	1.0	1.1	NS
Productivity loss, working days	40	0.0*	0.1	41	0.1	0.2	NS
Loss of income, unpaid working days	40	0.0	0.0	41	0.0	0.1	NS
Emergency visits	40	0.3	0.6	39	0.4	0.7	NS
Hospitalization	40	0.0	0.0	37	0.0	0.0	NS
Adverse drug reactions, n (%)	39	7	(17.9)	38	8	(21.1)	NS

Notes:

^aRescue medication (ATC: N02, M01, R06).

^*Level of significance 0.05 (between-group comparison, unpaired t-test, Mann–Whitney test, Fisher’s exact test). Level of significance 0.05 (within-group comparison, paired t-test, Wilcoxon signed-rank test).

Abbreviations: ATC/DDD, anatomical therapeutic classification/defined daily dose; NS, nonsignificant.